ARCHIVES

FDA To Regulate Products From Human Cells, Tissue

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: With money tight, support for 2015 goal is symbolic.

October 14, 2005

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

In Brief: NCI’s John Czajkowski Takes Executive Dean Position At Harvard Medical School

February 21, 2014

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

Community Tobacco Control Intervention Grants Funded By NCI.

October 27, 2000

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007